The first Solstice fund, was formed in 1995, and invested in 21 portfolio companies. In July 2001, Solstice Capital formed Solstice Capital II Limited Partnership, a $62 million early-stage venture fund, which has invested in 24 companies. Solstice Capital currently has $85 million of capital under management.
Solstice is committed to investing 50% of its capital in information technology and 50% in the following socially responsive investment categories:
* Alternative Energy * The Environment * Life Sciences * Education
High Throughput Genomics, (HTG) has developed an assay which aims to allow high throughput genotyping, quantitative and qualitative measurement of gene expression, and protein profiling and protein functional analysis for life sciences research, biotechnology, agricultural, pharmaceutical, public health and diagnostic markets.
MetaCarta is a provider of geographic intelligence solutions offering users map-driven geographic search, geographic referencing, and data visualization capabilities. MetaCarta products make data and unstructured content "location-aware" making that information geographically relevant. These innovative solutions aim to make it possible for customers to discover, visua...
More >>
MetaCarta is a provider of geographic intelligence solutions offering users map-driven geographic search, geographic referencing, and data visualization capabilities. MetaCarta products make data and unstructured content "location-aware" making that information geographically relevant. These innovative solutions aim to make it possible for customers to discover, visualize, and act on important location-based information.
<< Less
Carefx is a provider of an open and scalable Patient Information Aggregation platform that aims to provide clinicians real-time access to information residing in disparate applications. Extending the value of Single Sign-On (SSO) technology, Fusion from CarefxTM aids clinicians with sleek, intuitive and flexible access to patient information and satisfies IT imperati...
More >>
Carefx is a provider of an open and scalable Patient Information Aggregation platform that aims to provide clinicians real-time access to information residing in disparate applications. Extending the value of Single Sign-On (SSO) technology, Fusion from CarefxTM aids clinicians with sleek, intuitive and flexible access to patient information and satisfies IT imperatives by fully leveraging legacy investments within an open architecture.
<< Less
Arxan Technologies, Inc. (www.arxan.com) protects intellectual property from software piracy, tampering, reverse engineering and any manner of theft. We take software security beyond static obfuscation and encryption to dynamically defend, detect and react against application attacks. Arxan supports the full gamut of anti-tamper and robustness needs, from commercial a...
More >>
Arxan Technologies, Inc. (www.arxan.com) protects intellectual property from software piracy, tampering, reverse engineering and any manner of theft. We take software security beyond static obfuscation and encryption to dynamically defend, detect and react against application attacks. Arxan supports the full gamut of anti-tamper and robustness needs, from commercial anti-piracy to military grade assurance. Commercial businesses rely on Arxan to fortify software, license management and DRM applications from the billions of dollars lost to unauthorized use. The US department of defense and its contractors rely on Arxan Defense Systems, Inc. a subsidiary of Arxan Technologies, to deliver best of breed anti-tamper solutions to protect critical program information in military technology. Founded in 2001, Arxan Technologies has offices in Bethesda, Md., San Francisco, Calif., and West Lafayette, Ind.
<< Less
AmpliMed Corporation, a clinical-stage pharmaceutical company founded by oncologists is focused on a lead compound, Amplimexon, which per AmpliMed has shown early evidence of efficacy and low levels of toxicity. The company is focused on the development of small-molecule oncology drugs with novel mechanisms of action.
StrionAir is a air purification company that aims to utilize the electrical enhancement of a mechanical filter to achieve (1) high particle removal efficiency (especially sub micron size ), (2) at very low resistance to airflow, and (3) with a germicidal effect on mold, bacteria and viruses that also protects a building's air intake from a biological or radiological ...
More >>
StrionAir is a air purification company that aims to utilize the electrical enhancement of a mechanical filter to achieve (1) high particle removal efficiency (especially sub micron size ), (2) at very low resistance to airflow, and (3) with a germicidal effect on mold, bacteria and viruses that also protects a building's air intake from a biological or radiological terrorist attack. StrionAir's technology is based on research conducted by the Lawrence Livermore National Laboratories for the Department of Energy to protect nuclear facilities.
<< Less
Lumidigm is developing a biometric sensor for automatic identification of people. The Company spun out from InLight Solutions, Inc. and per the company has several patents pending. Its initial market focus is government, law enforcement, access control and surveillance.
Regenesis is engaged in the development, manufacturing, and sale of biomedical devices that promote healing and skin wound closure more quickly and cost-effectively than existing standards of wound treatment. The company's devices are based on its Cell Proliferation Induction (CPI) technology, in which electromagnetic signals trigger the repair and regeneration of so...
More >>
Regenesis is engaged in the development, manufacturing, and sale of biomedical devices that promote healing and skin wound closure more quickly and cost-effectively than existing standards of wound treatment. The company's devices are based on its Cell Proliferation Induction (CPI) technology, in which electromagnetic signals trigger the repair and regeneration of soft tissue cells.
<< Less
1 to 10 of 10 Investments | Go to Page 1
Why can I not access this page?
This page is accessible to a membership level higher than you. To improve your membership level you can try the following:
Review More Companies
Complete your profile
Improve your fanbase
Add/Edit more companies
Send a request to site admin at membership@chubbybrain.com requesting to upgrade your membership level. If your profile is eligible, your membership level will be upgraded and you will be notified.
Why can I not access this page?
This page is accessible to a membership level higher than you. To improve your membership level you can try the following:
Review More Companies
Complete your profile
Improve your fanbase
Add/Edit more companies
Send a request to site admin at membership@chubbybrain.com requesting to upgrade your membership level. If your profile is eligible, your membership level will be upgraded and you will be notified.
9,817 Investors 
.GIF){kind=logo}
